Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2012

   Amgen To Webcast Investor Meeting At Upcoming American Heart Association
                           Scientific Sessions 2012

PR Newswire

THOUSAND OAKS, Calif., Nov. 1, 2012

THOUSAND OAKS, Calif., Nov. 1, 2012 /PRNewswire/ --Amgen (NASDAQ:AMGN) will
host a webcast investor meeting at the American Heart Association (AHA)
Scientific Sessions 2012 on Tuesday, Nov. 6, at 7:00 p.m. Pacific Standard
Time. Sean E. Harper, M.D., executive vice president of Research and
Development at Amgen, along with members of Amgen's clinical development team
and clinical investigators, will participate at the investor meeting to
discuss data being presented at AHA. 

Live audio of the investor meeting will be simultaneously broadcast over the
Internet and will be available to members of the news media, investors and the
general public.

The webcast of the investor meeting, as with other selected presentations
regarding developments in Amgen's business given by management at certain
investor and medical conferences, can be found on Amgen's website,
www.amgen.com, under Investors. Information regarding presentation times,
webcast availability, and webcast links are noted on Amgen's Investor
Relations Events Calendar. The webcast will be archived and available for
replay for at least 72 hours after the event.

AboutAmgen

Amgendiscovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980,Amgenwas one of the first
companies to realize the new science's promise by bringing safe, effective
medicines from lab to manufacturing plant to patient.Amgentherapeutics have
changed the practice of medicine, helping millions of people around the world
in the fight against cancer, kidney disease, rheumatoid arthritis, bone
disease and other serious illnesses. With a deep and broad pipeline of
potential new medicines,Amgenremains committed to advancing science to
dramatically improve people's lives. For more information, visit
www.amgen.comand follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-559-0718 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

SOURCE Amgen

Website: http://www.amgen.com
 
Press spacebar to pause and continue. Press esc to stop.